Tag : botulinum toxin

Neurology

FDA Approves Botox for Lower-Limb Spasticity in Children

Newsemia
The FDA has approved Botox to ease lower-limb spasticity in children and adolescents aged 2 to 17 years, excluding spasticity caused by cerebral palsy. FDA...
Neurology

FDA OKs Botox for Upper Limb Spasticity in Children

Newsemia
Botox is the first neurotoxin to be approved in the US to treat upper limb spasticity for pediatric patients aged 2 years and older. FDA...
Neurology

AHS Releases Updated Guidance on Migraine Treatment

Newsemia
In response to recent advances in drug and device technology for treating migraine, the American Headache Society (AHS) has released new guidance on best preventive...
Neurology

High Rate of Waning Botox Efficacy in Dystonia, Spasticity

Newsemia
A ‘surprisingly high’ number of patients with dystonia or spasticity who receive botulinum neurotoxin type A develop neutralizing antibodies to the toxin over time, new...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy